Xiujun Cai

11.6k total citations · 3 hit papers
241 papers, 7.0k citations indexed

About

Xiujun Cai is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Xiujun Cai has authored 241 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Surgery, 76 papers in Molecular Biology and 56 papers in Oncology. Recurrent topics in Xiujun Cai's work include Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and MicroRNA in disease regulation (23 papers). Xiujun Cai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers) and MicroRNA in disease regulation (23 papers). Xiujun Cai collaborates with scholars based in China, United States and Germany. Xiujun Cai's co-authors include Xiao Liang, Yuelong Liang, Mingyu Chen, Hong Yu, Hui Lin, Junjie Xu, Sarun Juengpanich, Yifan Wang, Renan Jin and Jiasheng Cao and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Xiujun Cai

227 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting mutant p53 for cancer therapy: direct and indirect strategies

2021 343 citations Jiahao Hu, Jiasheng Cao et al. Journal of Hematology & Oncology profile →
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1

2020 332 citations Junjie Xu, Hui Lin et al. Signal Transduction and Targeted Therapy profile →
ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy

2021 184 citations Qiang Zheng, Yifan Wang et al. profile →

Peers

Countries citing papers authored by Xiujun Cai

Since Specialization

Citations

This map shows the geographic impact of Xiujun Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujun Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujun Cai more than expected).

Fields of papers citing papers by Xiujun Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiujun Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujun Cai. The network helps show where Xiujun Cai may publish in the future.

Co-authorship network of co-authors of Xiujun Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiujun Cai. A scholar is included among the top collaborators of Xiujun Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiujun Cai. Xiujun Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5G Remote Robot‐Assisted Hepatobiliary and Pancreatic Surgery: A Report of Five Cases and a Literature Review 2025 ·International Journal of Medical Robotics and Computer Assisted Surgery ·(unknown), Chao Ma, Xinyu Wu, (unknown), Xiao Liang, Zheyong Li, Xiujun Cai	3
2	Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy 2025 ·Small ·(unknown), (unknown), Win Topatana, (unknown), (unknown), Shijie Li, Jiadong Chen, (unknown), Ziyi Lu, (unknown), Tianen Chen, (unknown), Yuchao Sun, Xiujun Cai, Sarun Juengpanich, Mingyu Chen	3
3	Photocrosslinkable Hydrogel Microparticle Bioink for Digital‐Light‐Processing 3D Bioprinting 2025 ·Small Methods ·Shuiling Jin, Yanzhen Jing, Hui‐Hu Lu, (unknown), (unknown), Xuesong Ye, Yifan Wang, Xiujun Cai, Shangjing Xin	1
4	Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation 2025 ·Nature Communications ·Fubo Ji, (unknown), (unknown), (unknown), (unknown), Xianglei He, Yongzhi Zhao, Jiaxin Liu, Yan Zhang, (unknown), Jiong Shi, (unknown), Xiujun Cai, Bin Zhao, Jianping Jin, Pinglong Xu, Stéphanie Roessler, (unknown), Junfang Ji	4
5	Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer 2024 ·Molecular Cancer ·(unknown), Ziyuan Wang, Zhichao Ye, Yifan Wang, Xiujun Cai	28
6	Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma 2024 ·Journal of Experimental & Clinical Cancer Research ·Yongzhi Zhao, (unknown), (unknown), (unknown), (unknown), Liping Mao, (unknown), Lei Zhao, (unknown), (unknown), Xiujun Cai, Saiyong Zhu, Stéphanie Roessler, Junfang Ji	1
7	Safety of the stent-based diverting technique after low anterior resection in patients with rectal cancer 2024 ·Yifan Tong, Mingyu Chen, Zhangfa Song, Wen‐Bin Chen, Weiping Chen, Xuefeng Huang, Sheng Dai, Da Wang, (unknown), Danyang Wang, Tao Xiang, (unknown), Gang Wang, (unknown), Bingjun Bai, (unknown), Hui Liu, Lingfei Li, Xiujun Cai	0
8	Recent research progresses of bioengineered biliary stents 2024 ·Materials Today Bio ·(unknown), Zhichao Ye, Xiaofeng Wang, (unknown), Ziyuan Wang, Tiebin Yan, (unknown), (unknown), Yü Liu, Yifan Wang, Xiujun Cai	1
9	Machine learning algorithms to predict atypical metastasis of colorectal cancer patients after surgical resection 2023 ·Frontiers in Surgery ·Xiaoyan Yang, Wei Yu, (unknown), Xiujun Cai	3
10	Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer 2023 ·Nature Communications ·Sarun Juengpanich, Shijie Li, (unknown), (unknown), Jiadong Chen, (unknown), (unknown), Ziyi Lu, (unknown), Bin Zhang, Jiasheng Cao, Jiahao Hu, Jicheng Yu, Yanfang Wang, Win Topatana, Zhen Gu, Xiujun Cai, Mingyu Chen	66
11	A Knowledge-Guided Framework for Fine-Grained Classification of Liver Lesions Based on Multi-Phase CT Images 2022 ·IEEE Journal of Biomedical and Health Informatics ·(unknown), Qikui Zhu, (unknown), Jiongcheng Li, Xiujun Cai, Shuo Li, Xiaoqing Liu, Yizhou Yu	15
12	Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy 2022 ·Advanced Science ·Mingyu Chen, Sarun Juengpanich, Shijie Li, Win Topatana, Ziyi Lu, Qiang Zheng, Jiasheng Cao, Jiahao Hu, (unknown), Lidan Hou, Jiang Chen, Fang Chen, Yu Liu, Sukanda Jiansirisomboon, Zhen Gu, (unknown), Xiujun Cai	26
13	Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth 2022 ·Cell Communication and Signaling ·Jiahao Hu, Jiasheng Cao, Renan Jin, Bin Zhang, Win Topatana, Sarun Juengpanich, Shijie Li, Tianen Chen, Ziyi Lu, Xiujun Cai, Mingyu Chen	5
14	An integrated electrochemical POCT platform for ultrasensitive circRNA detection towards hepatocellular carcinoma diagnosis 2021 ·Biosensors and Bioelectronics ·Bin Zhang, Mingyu Chen, Jiasheng Cao, Yitao Liang, Tingting Tu, Jiahao Hu, Tianyu Li, Yu Cai, Shijie Li, Boqiang Liu, Junjie Xu, Bo Liang, Xuesong Ye, Xiujun Cai	47
15	Targeting mutant p53 for cancer therapy: direct and indirect strategies breakdown → 2021 ·Journal of Hematology & Oncology ·Jiahao Hu, Jiasheng Cao, Win Topatana, Sarun Juengpanich, Shijie Li, Bin Zhang, Jiliang Shen, Liuxin Cai, Xiujun Cai, Mingyu Chen	343
16	Development of synthetic lethality in cancer: molecular and cellular classification 2020 ·Signal Transduction and Targeted Therapy ·Shijie Li, Win Topatana, Sarun Juengpanich, Jiasheng Cao, Jiahao Hu, Bin Zhang, (unknown), Xiujun Cai, Mingyu Chen	70
17	Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning 2020 ·npj Precision Oncology ·Mingyu Chen, Bin Zhang, Win Topatana, Jiasheng Cao, (unknown), Sarun Juengpanich, Qijiang Mao, Hong Yu, Xiujun Cai	169
18	IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin 2020 ·Nature Communications ·Miao Tian, Xiumei Wang, Jihong Sun, Wenlong Lin, Lumin Chen, Shengduo Liu, Ximei Wu, Liyun Shi, Pinglong Xu, Xiujun Cai, Xiaojian Wang	64
19	MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma 2018 ·BioMed Research International ·(unknown), Shibo Ying, Xiujun Cai	14
20	Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression 2016 ·Molecular Cancer Therapeutics ·Liang Shi, Hui Lin, Gonghui Li, (unknown), Junjie Xu, Yin Sun, Wen‐Lung Ma, Shuyuan Yeh, Xiujun Cai, Chawnshang Chang	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact